LEXINGTON, Mass. and AMSTERDAM, Nov. 03, 2025 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing ...

The FDA is said to be making a U-turn on uniQure’s one-time gene therapy candidate for Huntington’s disease despite the treatment being hailed as a game-changer. | FDA is said to be making a U-turn on ...

Pivotal results from uniQure’s gene therapy for Huntington’s disease have brought new light to patients who have known only ...

UniQure said the U.S. Food and Drug Administration no longer agreed that clinical data for the Dutch company's gene therapy ...

HUNTINGTON, Texas (KETK) — An ambulance “literally” exploded while transporting a patient on Friday afternoon, the Huntington ...

Last month, “historic positive results” from uniQure’s gene therapy snapped the Huntington’s community out of years of failure. As the biotech prepares to submit for FDA approval, BioSpace looks at ...

However, in late September 2025, scientists successfully treated Huntington’s for the first time in a ground-breaking study.

Please provide your email address to receive an email when new articles are posted on . The Huntington Disease Health Index was used for patient-reported symptom burden in KINECT-HD trial. The HD-HI ...

PERRY, N.Y. — Reminders of Huntington’s disease populate Tammy Stewart’s apartment. They are also glimpses into her future. On the table beside the couch sit framed pictures of her dad, Roy, and one ...

Across clinical measures, Black patients with Huntington's had worse cognitive and motor symptoms at baseline, reported Daniel Claassen, MD, MS, of Vanderbilt University Medical Center in Nashville, ...

HUNTINGTON, Texas (KLTV) - A patient was evacuated from an ambulance after the motor exploded at a Huntington red light. According to Huntington police, while waiting at a red light on U.S. 69 in ...